Targeting glutamine metabolism as a therapeutic strategy for cancer

J Jin, JK Byun, YK Choi, KG Park - Experimental & Molecular Medicine, 2023 - nature.com
Proliferating cancer cells rely largely on glutamine for survival and proliferation. Glutamine
serves as a carbon source for the synthesis of lipids and metabolites via the TCA cycle, as …

Emerging therapies in cancer metabolism

Y Xiao, TJ Yu, Y Xu, R Ding, YP Wang, YZ Jiang… - Cell Metabolism, 2023 - cell.com
Metabolic reprogramming in cancer is not only a biological hallmark but also reveals
treatment vulnerabilities. Numerous metabolic molecules have shown promise as treatment …

Amino acid metabolism in health and disease

ZN Ling, YF Jiang, JN Ru, JH Lu, B Ding… - Signal Transduction and …, 2023 - nature.com
Amino acids are the building blocks of protein synthesis. They are structural elements and
energy sources of cells necessary for normal cell growth, differentiation and function. Amino …

Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma

T Liu, C Han, P Fang, Z Ma, X Wang, H Chen… - Journal of Hematology & …, 2022 - Springer
Background Besides featured glucose consumption, recent studies reveal that cancer cells
might prefer “addicting” specific energy substrates from the tumor microenvironment (TME); …

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment

G Ma, Z Zhang, P Li, Z Zhang, M Zeng, Z Liang… - Cell Communication and …, 2022 - Springer
Metabolic reprogramming and immune escape play a major role in tumorigenesis.
Increasing number of studies have shown that reprogramming of glutamine metabolism is a …

Altered metabolism in cancer: Insights into energy pathways and therapeutic targets

M Tufail, CH Jiang, N Li - Molecular Cancer, 2024 - Springer
Cancer cells undergo significant metabolic reprogramming to support their rapid growth and
survival. This study examines important metabolic pathways like glycolysis, oxidative …

O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1

Q Zhu, H Zhou, L Wu, Z Lai, D Geng, W Yang… - Nature Chemical …, 2022 - nature.com
Oncogenic Kras-activated pancreatic ductal adenocarcinoma (PDAC) cells highly rely on an
unconventional glutamine catabolic pathway to sustain cell growth. However, little is known …

Cold and hot tumors: from molecular mechanisms to targeted therapy

B Wu, B Zhang, B Li, H Wu, M Jiang - Signal Transduction and Targeted …, 2024 - nature.com
Immunotherapy has made significant strides in cancer treatment, particularly through
immune checkpoint blockade (ICB), which has shown notable clinical benefits across …

[HTML][HTML] Loss of CD4+ T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection

EE West, NS Merle, MM Kamiński, G Palacios… - Immunity, 2023 - cell.com
Summary Arginase 1 (Arg1), the enzyme catalyzing the conversion of arginine to ornithine,
is a hallmark of IL-10-producing immunoregulatory M2 macrophages. However, its …

A novel Alzheimer's disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy

Z Wu, P Liu, B Huang, S Deng, Z Song, X Huang… - Scientific Reports, 2023 - nature.com
Alzheimer's disease (AD) is characterized as a distinct onset and progression of cognitive
and functional decline associated with age, as well as a specific neuropathology. It has been …